For example, Song et al. utilized CRISPR/Cas9 to knock out the GLA gene and created a human embryonic stem cell (hESC)-derived model of Fabry disease (FD)-associated hypertrophic cardiomyopathy [83]. This evidence concerns the gene GLA and Fabry disease.